{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:38:54Z","timestamp":1792784334086,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20234Y0113"],"award-info":[{"award-number":["20234Y0113"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271108"],"award-info":[{"award-number":["82271108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Science and Technology of China","award":["2020YFA0113100"],"award-info":[{"award-number":["2020YFA0113100"]}],"id":[{"id":"https:\/\/ror.org\/02kv4zf79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Shanghai","award":["24ZR1470100"],"award-info":[{"award-number":["24ZR1470100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05298-2","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T14:18:49Z","timestamp":1763129929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Umbilical Cord Mesenchymal Stromal Cell-Derived Extracellular Vesicles Transfer CD59 to Astrocytes to Alleviate Complement-Dependent Cytotoxicity"],"prefix":"10.1007","volume":"63","author":[{"given":"Qi","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjian","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlong","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangtai","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Tong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"5298_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"5298_CR2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001068","author":"FC Oertel","year":"2021","unstructured":"Oertel FC, Specovius S, Zimmermann HG et al (2021) Retinal optical coherence tomography in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001068","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"5298_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473\u2013477. https:\/\/doi.org\/10.1084\/jem.20050304","journal-title":"J Exp Med"},{"key":"5298_CR4","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/1744666X.2022.2105205","volume":"18","author":"P Stathopoulos","year":"2022","unstructured":"Stathopoulos P, Dalakas MC (2022) The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders Expert. Rev Clin Immunol 18:933\u2013945. https:\/\/doi.org\/10.1080\/1744666X.2022.2105205","journal-title":"Rev Clin Immunol"},{"key":"5298_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577387","volume":"348","author":"X Ma","year":"2020","unstructured":"Ma X, Kermode AG, Hu X, Qiu W (2020) NMOSD acute attack: understanding, treatment and innovative treatment prospect. J Neuroimmunol 348:577387. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577387","journal-title":"J Neuroimmunol"},{"key":"5298_CR6","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3389\/fimmu.2019.01990","volume":"10","author":"C Kaegi","year":"2019","unstructured":"Kaegi C, Wuest B, Schreiner J et al (2019) Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders. Front Immunol 10:1990. https:\/\/doi.org\/10.3389\/fimmu.2019.01990","journal-title":"Front Immunol"},{"key":"5298_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s40263-022-00949-7","volume":"36","author":"L Nie","year":"2022","unstructured":"Nie L, Blair HA (2022) Inebilizumab: a review in neuromyelitis optica spectrum disorder. CNS Drugs 36:1133\u20131141. https:\/\/doi.org\/10.1007\/s40263-022-00949-7","journal-title":"CNS Drugs"},{"key":"5298_CR8","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1007\/s10792-019-01090-z","volume":"39","author":"W Song","year":"2019","unstructured":"Song W, Qu Y, Huang X (2019) Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders\/. Int Ophthalmol 39:2477\u20132483. https:\/\/doi.org\/10.1007\/s10792-019-01090-z","journal-title":"Int Ophthalmol"},{"key":"5298_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03667-3","volume":"24","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wu J, Lin J, Lin S, Lin A (2024) Characteristics of recurrence in area postrema-onset NMO spectrum disorder - a retrospective cohort study. BMC Neurol 24:165","journal-title":"BMC Neurol"},{"key":"5298_CR10","doi-asserted-by":"publisher","unstructured":"Zhidu S, Ying T, Rui J, Chao Z (2024) Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities. Stem Cell Res Ther 15:266. https:\/\/doi.org\/10.1186\/s13287-024-03885-z","DOI":"10.1186\/s13287-024-03885-z"},{"key":"5298_CR11","doi-asserted-by":"publisher","unstructured":"Shariati A, Nemati R, Sadeghipour Y, et al (2020) Mesenchymal stromal cells (MSCs) for neurodegenerative disease: a promising frontier. Eur J Cell Biol. 99:151097. https:\/\/doi.org\/10.1016\/j.ejcb.2020.151097","DOI":"10.1016\/j.ejcb.2020.151097"},{"key":"5298_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/cns.12559","volume":"22","author":"Y Fu","year":"2016","unstructured":"Fu Y, Yan Y, Qi Y et al (2016) Impact of autologous mesenchymal stem cell infusion on neuromyelitis optica spectrum disorder: a pilot, 2-year observational study. CNS Neurosci Ther 22:677\u2013685. https:\/\/doi.org\/10.1111\/cns.12559","journal-title":"CNS Neurosci Ther"},{"key":"5298_CR13","doi-asserted-by":"publisher","unstructured":"Liu B, Wei Y, He J, et al (2024) Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy. Stem Cell Res Ther 15:120. https:\/\/doi.org\/10.1186\/s13287-024-03715-2","DOI":"10.1186\/s13287-024-03715-2"},{"key":"5298_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-075138","volume":"14","author":"L Huang","year":"2024","unstructured":"Huang L, Zou J, Zhang Y, Gu J, Wu J, Zhang C (2024) Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China. BMJ Open 14:e075138. https:\/\/doi.org\/10.1136\/bmjopen-2023-075138","journal-title":"BMJ Open"},{"key":"5298_CR15","doi-asserted-by":"publisher","unstructured":"Hum C, Tahir U, Mei SHJ, et al (2024) Efficacy and safety of umbilical cord-derived mesenchymal stromal cell therapy in preclinical models of sepsis: a systematic review and meta-analysis. Stem Cells Transl Med 13:346\u2013361. https:\/\/doi.org\/10.1093\/stcltm\/szae003","DOI":"10.1093\/stcltm\/szae003"},{"key":"5298_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10238-016-0427-0","volume":"17","author":"D Wang","year":"2017","unstructured":"Wang D, Niu L, Feng X et al (2017) Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study. Clin Exp Med 17:333\u2013340. https:\/\/doi.org\/10.1007\/s10238-016-0427-0","journal-title":"Clin Exp Med"},{"key":"5298_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01059-y","volume":"7","author":"L Cheng","year":"2022","unstructured":"Cheng L, Wang S, Peng C et al (2022) Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1\/2a, single-arm study. Signal Transduct Target Ther 7:263","journal-title":"Signal Transduct Target Ther"},{"key":"5298_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13287-023-03484-4","volume":"14","author":"D Li","year":"2023","unstructured":"Li D, Ou Q, Shen Q et al (2023) Subconjunctival injection of human umbilical cord mesenchymal stem cells alleviates experimental allergic conjunctivitis via regulating T cell response. Stem Cell Res Ther 14:281. https:\/\/doi.org\/10.1186\/s13287-023-03484-4","journal-title":"Stem Cell Res Ther"},{"key":"5298_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-02782-7","volume":"13","author":"SA Jasim","year":"2022","unstructured":"Jasim SA, Yumashev AV, Abdelbasset WK et al (2022) Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases. Stem Cell Res Ther 13:101","journal-title":"Stem Cell Res Ther"},{"key":"5298_CR20","doi-asserted-by":"publisher","unstructured":"Yao XY, Xie L, Cai Y, et al (2022) Human umbilical cord mesenchymal stem cells to treat neuromyelitis optica spectrum disorder (hUC-MSC-NMOSD): a study protocol for a prospective, multicenter, randomized, placebo-controlled clinical trial. Front Neurol 13:860083. https:\/\/doi.org\/10.3389\/fneur.2022.860083","DOI":"10.3389\/fneur.2022.860083"},{"key":"5298_CR21","doi-asserted-by":"publisher","first-page":"9625798","DOI":"10.1155\/2020\/9625798","volume":"2020","author":"C Hu","year":"2020","unstructured":"Hu C, La H, Wei X et al (2020) Transplantation site affects the outcomes of adipose-derived stem cell-based therapy for retinal degeneration Stem Cells Int 2020:9625798. https:\/\/doi.org\/10.1155\/2020\/9625798","journal-title":"Transplantation site affects the outcomes of adipose-derived stem cell-based therapy for retinal degeneration Stem Cells Int"},{"key":"5298_CR22","doi-asserted-by":"publisher","unstructured":"Zhou J, Li F, Jia B, et al (2024) Intranasal delivery of small extracellular vesicles reduces the progress of amyotrophic lateral sclerosis and the overactivation of complement-coagulation cascade and NF-kB signaling in SOD1(G93A) mice. J Nanobiotechnology 22:503. https:\/\/doi.org\/10.1186\/s12951-024-02764-2","DOI":"10.1186\/s12951-024-02764-2"},{"key":"5298_CR23","doi-asserted-by":"publisher","first-page":"1586174","DOI":"10.3389\/fimmu.2025.1586174","volume":"16","author":"X Peng","year":"2025","unstructured":"Peng X, Shi W, Yu H et al (2025) Small extracellular vesicles from human umbilical cord mesenchymal stem cells delivering miR-202\u20135p alleviate renal ischemia-reperfusion injury by targeting the GOLIM4\/PI3K\/AKT axis. Front Immunol 16:1586174. https:\/\/doi.org\/10.3389\/fimmu.2025.1586174","journal-title":"Front Immunol"},{"key":"5298_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5114\/ceji.2024.143726","volume":"49","author":"C Ozturk","year":"2024","unstructured":"Ozturk C, Halbutogullari ZS (2024) Immune regulation is more effective in the U937 inflammation model with mesenchymal stem cell extracellular vesicles stimulated by pro-inflammatory cytokines. Cent Eur J Immunol 49:282\u2013299. https:\/\/doi.org\/10.5114\/ceji.2024.143726","journal-title":"Cent Eur J Immunol"},{"key":"5298_CR25","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.4103\/1673-5374.371376","volume":"18","author":"Z Yang","year":"2023","unstructured":"Yang Z, Liang Z, Rao J et al (2023) Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis Neural Regen Res. 18:2406\u20132412. https:\/\/doi.org\/10.4103\/1673-5374.371376","journal-title":"Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis Neural Regen Res."},{"key":"5298_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137371","author":"G Zanirati","year":"2024","unstructured":"Zanirati G, Dos Santos PG, Alcara AM et al (2024) Extracellular vesicles: the next generation of biomarkers and treatment for central nervous system diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25137371","journal-title":"Int J Mol Sci"},{"key":"5298_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/imm.70008","author":"RS Cooke","year":"2025","unstructured":"Cooke RS, Spicer BA, Harrison RA, Dunstone MA, Morgan BP, Zelek WM (2025) CD59, disulphide-locked human C9 and horse C9 inhibit human membrane attack complex assembly by similar mechanisms. Immunology. https:\/\/doi.org\/10.1111\/imm.70008","journal-title":"Immunology"},{"key":"5298_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/scrt8","volume":"1","author":"LG Chase","year":"2010","unstructured":"Chase LG, Lakshmipathy U, Solchaga LA, Rao MS, Vemuri MC (2010) A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther 1:8. https:\/\/doi.org\/10.1186\/scrt8","journal-title":"Stem Cell Res Ther"},{"key":"5298_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-01690-y","volume":"11","author":"X Yi","year":"2020","unstructured":"Yi X, Chen F, Liu F et al (2020) Comparative separation methods and biological characteristics of human placental and umbilical cord mesenchymal stem cells in serum-free culture conditions. Stem Cell Res Ther 11:183","journal-title":"Stem Cell Res Ther"},{"key":"5298_CR30","doi-asserted-by":"publisher","unstructured":"Cooney DS, Wimmers EG, Ibrahim Z, et al (2016) Mesenchymal stem cells enhance nerve regeneration in a rat sciatic nerve repair and hindlimb transplant model. Sci Rep 6:31306.\u00a0https:\/\/doi.org\/10.1038\/srep31306","DOI":"10.1038\/srep31306"},{"key":"5298_CR31","doi-asserted-by":"publisher","unstructured":"Wang P., Zhang Y., Zhao J., Jiang B. (2015) Intramuscular injection of bone marrow mesenchymal stem cells with small gap neurorrhaphy for peripheral nerve repair Neurosci Lett. 585:119\u2013125.\u00a0https:\/\/doi.org\/10.1016\/j.neulet.2014.11.039","DOI":"10.1016\/j.neulet.2014.11.039"},{"key":"5298_CR32","doi-asserted-by":"publisher","unstructured":"Choi BY, Song JJ, Chang SO, Kim SU, Oh SH (2012) Intravenous administration of human mesenchymal stem cells after noise- or drug-induced hearing loss in rats. Acta Otolaryngol 132(Suppl 1):S94\u2013102. https:\/\/doi.org\/10.3109\/00016489.2012.660731","DOI":"10.3109\/00016489.2012.660731"},{"key":"5298_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05199-5","volume":"13","author":"X Zhu","year":"2022","unstructured":"Zhu X, Chen Z, Wang L et al (2022) Direct conversion of human umbilical cord mesenchymal stem cells into retinal pigment epithelial cells for treatment of retinal degeneration. Cell Death Dis 13:785","journal-title":"Cell Death Dis"},{"key":"5298_CR34","doi-asserted-by":"publisher","unstructured":"Liang Q, Li Q, Ren B, Yin ZQ (2022) Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats. BMC Ophthalmol 22:67. https:\/\/doi.org\/10.1186\/s12886-021-02171-3","DOI":"10.1186\/s12886-021-02171-3"},{"key":"5298_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.exer.2013.12.010","volume":"119","author":"Y Matsumoto","year":"2014","unstructured":"Matsumoto Y, Kanamori A, Nakamura M, Takahashi T, Nakashima I, Negi A (2014) Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve. Exp Eye Res 119:61\u201369. https:\/\/doi.org\/10.1016\/j.exer.2013.12.010","journal-title":"Exp Eye Res"},{"key":"5298_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0746-9","volume":"13","author":"CM Felix","year":"2016","unstructured":"Felix CM, Levin MH, Verkman AS (2016) Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G. J Neuroinflammation 13:275","journal-title":"J Neuroinflammation"},{"key":"5298_CR37","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2013.0502","author":"M Li","year":"2014","unstructured":"Li M, Zeringer E, Barta T, Schageman J, Cheng A, Vlassov AV (2014) Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers. Philos Trans R Soc Lond B Biol Sci. https:\/\/doi.org\/10.1098\/rstb.2013.0502","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"5298_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/ki.1996.310","volume":"50","author":"M Nangaku","year":"1996","unstructured":"Nangaku M, Meek RL, Pippin J et al (1996) Transfected CD59 protects mesangial cells from injury induced by antibody and complement. Kidney Int 50:257\u2013266. https:\/\/doi.org\/10.1038\/ki.1996.310","journal-title":"Kidney Int"},{"key":"5298_CR39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/978-1-4614-3209-8_55","volume":"801","author":"G Schnabolk","year":"2014","unstructured":"Schnabolk G, Tomlinson S, Rohrer B (2014) The complement regulatory protein CD59: insights into attenuation of choroidal neovascularization. Adv Exp Med Biol 801:435\u2013440. https:\/\/doi.org\/10.1007\/978-1-4614-3209-8_55","journal-title":"Adv Exp Med Biol"},{"key":"5298_CR40","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.ymthe.2018.03.012","volume":"26","author":"B Kumar","year":"2018","unstructured":"Kumar B, Cashman SM, Kumar-Singh R (2018) Complement-mediated activation of the NLRP3 inflammasome and its inhibition by AAV-mediated delivery of CD59 in a model of uveitis. Mol Ther 26:1568\u20131580. https:\/\/doi.org\/10.1016\/j.ymthe.2018.03.012","journal-title":"Mol Ther"},{"key":"5298_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbrep.2016.05.012","volume":"7","author":"S Nishiyama","year":"2016","unstructured":"Nishiyama S, Misu T, Nuriya M et al (2016) Complement-dependent and -independent aquaporin 4-antibody-mediated cytotoxicity in human astrocytes: pathogenetic implications in neuromyelitis optica. Biochem Biophys Rep 7:45\u201351. https:\/\/doi.org\/10.1016\/j.bbrep.2016.05.012","journal-title":"Biochem Biophys Rep"},{"key":"5298_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaut.2014.02.011","volume":"53","author":"H Zhang","year":"2014","unstructured":"Zhang H, Verkman AS (2014) Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. J Autoimmun 53:67\u201377. https:\/\/doi.org\/10.1016\/j.jaut.2014.02.011","journal-title":"J Autoimmun"},{"key":"5298_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbi.2017.04.023","volume":"65","author":"Z Wang","year":"2017","unstructured":"Wang Z, Guo W, Liu Y et al (2017) Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes. Brain Behav Immun 65:173\u2013182. https:\/\/doi.org\/10.1016\/j.bbi.2017.04.023","journal-title":"Brain Behav Immun"},{"issue":"5","key":"5298_CR44","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/cancers13051126","volume":"13","author":"N Franceschini","year":"2021","unstructured":"Franceschini N, Verbruggen B, Tryfonidou MA et al (2021) Transformed canine and murine mesenchymal stem cells as a model for sarcoma with complex genomics. Cancers (Basel) 13(5):1126. https:\/\/doi.org\/10.3390\/cancers13051126","journal-title":"Cancers (Basel)"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05298-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05298-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05298-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T20:03:55Z","timestamp":1763150635000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05298-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5298"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05298-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The isolation of hUCMSCs was approved by the Ethics Committee of the Hangzhou First People\u2019s Hospital (no. ZN-20211227\u20130147-01). Clinical trial number: not applicable. All animal procedures were carried out in accordance with the guidelines of the animal experimentation ethics committee of Tongji University (approved no. TJAA09623401).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}